Patent · US Active

Dialysis membrane having improved ability for removal of middle molecules

US7811507B2 · kind B2 · utility

14Cited by
8References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2005
Grant dateOct 12, 2010
Priority date
Expiry dateDec 6, 2026

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T428/2975
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

A hydrophilic semipermeable hollow-fibre membrane for blood treatment, with an integrally asymmetric structure based on a synthetic polymer. The hollow-fiber membrane possess on its inner surface a separating layer and an adjoining open-pored supporting layer, and has an ultrafiltration rate in albumin solution of 5 to ≦25 ml/(h·m2·mmHg). The hollow fiber membrane is free from pore-stabilizing additives and has a maximum sieving coefficient for albumin of 0.005 and a sieving coefficient of cytochrome c that satisfies the equationSCcc≧5·10−5·UFRAlb3−0.004·UFRAlb2+0.1081·UFRAlb−0.25.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.